Global and Regional Insulin Glargine Market Research Report 2017 [Report Updated: 11102017] Prices from USD $3500
Summary
Insulin glargine, marketed under the names Lantus among others, is a longacting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. It consists of microcrystals that slowly release insulin, giving a long duration of action of 18 to 26 hours, with a "peakless" profile according to the insulin glargine package insert.
Market Segment as follows:
By Region
AsiaPacific
North America
Europe
South America
Middle East Africa
By Type
Single Dose Vial
Prefilled Syringe
By Application
Treat type 1 diabetes
Treat type 2 diabetes
By Company
SanofiAventis
Ganlee
Biocon
The main contents of the report including:
Section 1:
Product definition, type and application, global and regional market overview;
Section 2:
Global and regional Market competition by company;
Section 3:
Global and regional sales revenue, volume and price by type;
Section 4:
Global and regional sales revenue, volume and price by application;
Section 5:
Regional export and import;
Section 6:
Company information, business overview, sales data and product specifications;
Section 7:
Industry chain and raw materials;
Section 8:
SWOT and Porter's Five Forces;
Section 9:
Conclusion.
Original Article: Global and Regional Insulin Glargine Market Research Report 2017 [Report Updated: 11102017] Prices from USD $3500
